全文获取类型
| 收费全文 | 79002篇 |
| 免费 | 7764篇 |
| 国内免费 | 3383篇 |
专业分类
| 耳鼻咽喉 | 128篇 |
| 儿科学 | 4149篇 |
| 妇产科学 | 380篇 |
| 基础医学 | 6284篇 |
| 口腔科学 | 566篇 |
| 临床医学 | 8325篇 |
| 内科学 | 13862篇 |
| 皮肤病学 | 683篇 |
| 神经病学 | 1921篇 |
| 特种医学 | 1893篇 |
| 外国民族医学 | 7篇 |
| 外科学 | 28461篇 |
| 综合类 | 10178篇 |
| 现状与发展 | 16篇 |
| 一般理论 | 5篇 |
| 预防医学 | 2394篇 |
| 眼科学 | 1294篇 |
| 药学 | 3961篇 |
| 33篇 | |
| 中国医学 | 3098篇 |
| 肿瘤学 | 2511篇 |
出版年
| 2024年 | 150篇 |
| 2023年 | 1494篇 |
| 2022年 | 1668篇 |
| 2021年 | 3631篇 |
| 2020年 | 3228篇 |
| 2019年 | 3507篇 |
| 2018年 | 3381篇 |
| 2017年 | 3142篇 |
| 2016年 | 3081篇 |
| 2015年 | 3026篇 |
| 2014年 | 5141篇 |
| 2013年 | 5859篇 |
| 2012年 | 3985篇 |
| 2011年 | 4753篇 |
| 2010年 | 4160篇 |
| 2009年 | 4074篇 |
| 2008年 | 4170篇 |
| 2007年 | 4269篇 |
| 2006年 | 4150篇 |
| 2005年 | 3579篇 |
| 2004年 | 2970篇 |
| 2003年 | 2522篇 |
| 2002年 | 2070篇 |
| 2001年 | 1791篇 |
| 2000年 | 1415篇 |
| 1999年 | 1109篇 |
| 1998年 | 996篇 |
| 1997年 | 862篇 |
| 1996年 | 816篇 |
| 1995年 | 699篇 |
| 1994年 | 756篇 |
| 1993年 | 459篇 |
| 1992年 | 563篇 |
| 1991年 | 437篇 |
| 1990年 | 285篇 |
| 1989年 | 286篇 |
| 1988年 | 281篇 |
| 1987年 | 206篇 |
| 1986年 | 165篇 |
| 1985年 | 185篇 |
| 1984年 | 160篇 |
| 1983年 | 85篇 |
| 1982年 | 111篇 |
| 1981年 | 101篇 |
| 1980年 | 68篇 |
| 1979年 | 69篇 |
| 1978年 | 62篇 |
| 1977年 | 52篇 |
| 1976年 | 44篇 |
| 1975年 | 27篇 |
排序方式： 共有10000条查询结果，搜索用时 443 毫秒
51.
52.
53.
54.
55.
56.
57.
Worsening pneumonitis due to a pharmacokinetic drug–drug interaction between everolimus and voriconazole in a renal transplant patient 
下载免费PDF全文
下载免费PDF全文 58.
AbstractBackground: Approximately, 30–40% of patients experienced hearing loss under regular hemodialysis.Objective: This study reviewed our experience on treating acute hearing loss in patients under regular hemodialysis over the past two decades.Methods: Twenty-six patients having acute hearing loss under hemodialysis were divided into two groups based on their etiologies. Sixteen patients (16 ears) with sudden sensorineural hearing loss (SSHL) were assigned to Group A and 10 patients (13 ears) with endolymphatic hydrops (EH) were assigned to Group B.Results: No significant difference was noted between Groups A and B, regardless of hemodialysis duration, clinical manifestation, underlying systemic diseases, blood examination, and vestibular test battery. In contrast, serum osmolality was significantly lower in Group B (292?±?11 mOsm/kg) than in Group A (310?±?11 mOsm/kg). Furthermore, Group B (40?±?14?dB) had better mean hearing level than Group A (87?±?21?dB) in the initial audiogram, and a higher hearing improvement rate (69%) than Group A (19%).Conclusions and significance: Both SSHL and EH are major causes for precipitating acute hearing loss in hemodialysis patients. Compared to SSHL, the less deteriorated MHL and lower serum osmolality in EH provide two clues for differentiating acute hearing loss in hemodialysis patients. 相似文献
59.
Roberto V.P. Ribeiro Mitesh V. Badiwala Danny Ramzy Laura C. Tumiati Vivek Rao 《The Journal of thoracic and cardiovascular surgery》2019,157(2):615-625.e1
Objective
Hypertonic saline (HTS) has potent immune and vascular effects. We assessed recipient pretreatment with HTS on allograft function in a porcine model of heart transplantation and hypothesized that HTS infusion would limit endothelial and left ventricular (LV) dysfunction following transplantation.Methods
Heart transplants were performed after 6 hours of cold ischemic storage. Recipient pigs were randomized to treatment with or without HTS (7.5% NaCl) before cardiopulmonary bypass (CPB). Using a myograft apparatus, coronary artery endothelial-dependent (Edep) and -independent (Eind) relaxation was assessed. LV performance was determined using pressure-volume loop analysis. Pulmonary interleukin (IL)-2, IL-6, and tumor necrosis factor (TNF)-α expression was measured.Results
Weaning from CPB and LV performance after transplantation were improved in HTS-treated animals. Successful weaning from CPB was greater in the HTS-treated hearts (8 of 8 vs 2 of 8; P < .05). Mean LV functional recovery was improved in the HTS-treated animals, as assessed by preload recruitable stroke work (65 ± 10% vs 27 ± 10%; P < .001) and end-systolic elastance (55 ± 7% vs 37 ± 4%; P < .001). Treatment with HTS resulted in improved Edep (mean maximum elastance [Emax], 56 ± 5% vs 37 ± 7%; P < .001) and Eind (mean Emax%, 77 ± 6% vs 52 ± 4%; P < .001) vasorelaxation compared with control. Pulmonary expression of IL-2, IL-6, and TNF-α increased following transplantation, whereas HTS therapy attenuated IL production (P < .001). Transplantation increased plasma TNF-α levels and LV TNF-α expression, whereas HTS prevented this up-regulation (P < .001).Conclusions
Recipient HTS pretreatment preserves allograft vasomotor and LV function, and HTS therapy limits CPB-induced injury. HTS may be a novel recipient intervention to prevent graft dysfunction. 相似文献60.